Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
Open accessThe DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer. METHODS: A total of 1851 women for whom follow-up data were available and nodal status was known underwent randomly assigned treatment consisting of total mastectomy, lumpectomy alone, or lumpectomy and breast irradiation. Kaplan-Meier and cumulative-incidence estimates of the outcome were obtained. RESULTS: The cumulative incidence of recurrent tumor in the ipsilateral breast was 14.3 percent in the women who underwent lumpectomy and breast irradiation, as compared with 39.2 percent in the women who underwent lumpectomy without irradiation (P<0.001). No significant differences were observed among the three groups of women with respect to disease-free survival, distant-disease-free survival, or overall survival. The hazard ratio for death among the women who underwent lumpectomy alone, as compared with those who underwent total mastectomy, was 1.05 (95 percent confidence interval, 0.90 to 1.23; P=0.51). The hazard ratio for death among the women who underwent lumpectomy followed by breast irradiation, as compared with those who underwent total mastectomy, was 0.97 (95 percent confidence interval, 0.83 to 1.14; P=0.74). Among the lumpectomy-treated women whose surgical specimens had tumor-free margins, the hazard ratio for death among the women who underwent postoperative breast irradiation, as compared with those who did not, was 0.91 (95 percent confidence interval, 0.77 to 1.06; P=0.23). Radiation therapy was associated with a marginally significant decrease in deaths due to breast cancer. This decrease was partially offset by an increase in deaths from other causes. CONCLUSIONS: Lumpectomy followed by breast irradiation continues to be appropriate therapy for women with breast cancer, provided that the margins of resected specimens are free of tumor and an acceptable cosmetic result can be obtained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has resulted in improved outcomes in a number of different cancers (2, 342–350).”
From Adrenocortical carcinoma (2014) · cites this paper as [344]
In the citing paper
“Breast-conserving surgery combined with radiation therapy is standard treatment for early stage breast cancer and provides equivalent survival to mastectomy [20-27].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [20]
In the citing paper
“and it can be greatly reduced by radiotherapy. 4,5”
In the citing paper
“The risk of recurrence in a conserved breast can be substantial even in node-negative disease that has been confirmed by axillary clearance”
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Self-citationVeronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Research works printed but not linked: 4
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
- Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Bethesda, Md.: National Cancer Institute, 1992:19-25. (NIH publication no. 90-3187.)
- 10.1007/BF01655182 · DOI
- Veronesi U, 1983, Int Adv Surg Oncol, 6, 141
Cited by
Items 701–800 of 1,005
Lin, J., Yeh, D., Yeh, H., Chang, C.-F., & Lin, J. (2015) · Medical dosimetry · doi:10.1016/j.meddos.2015.05.003 · Cited by 65
Benefits, risks, and safety of external beam radiation therapy for breast cancer
Halyard, M. Y., Brown, L. C., & Mutter, R. W. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s55552 · Cited by 88
“A similar trial, NSABP B-06, was conducted in the United States, in which women with tumors 4 cm or less in diameter were treated with lumpectomy (surgical extirpation of tumor and sufficient surrounding normal tissues to achieve negative surgical margins) alone, lumpectomy plus RT, or TM.(7) In addition to confirming…”
Voti, L., Richardson, L. C., dos Reis, I. M., Fleming, L. E., MacKinnon, J., & Coebergh, J. W. W. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9050-6 · Cited by 65
“As a result, these 2 treatment modalities have become the standard of care for early breast cancer, and multiple medical societies have re c o m m e n d e d t h a t women should be given a choice between these 2 therapies when diagnosed with local breast cancer [1,2,3,5].”
An update on the medical management of breast cancer
Yeo, B. J., Turner, N. C., & Jones, A. L. (2014) · BMJ · doi:10.1136/bmj.g3608 · Cited by 75
D’Halluin, F., Tas, P., Rouquette, S., Bendavid‐Athias, C., Foucher, F., Meshba, H., Blanchot, J., Coué, O., & Lévêque, J. (2009) · The Breast · doi:10.1016/j.breast.2009.05.002 · Cited by 65
Hill‐Kayser, C. E., Vachani, C. C., Hampshire, M. K., Lullo, G. A. D., & Metz, J. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.013 · Cited by 65
Rong, Y., Walston, S., Welliver, M. X., Chakravarti, A., & Quick, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097933 · Cited by 65
“cancer-related mortality [1,2].”
Ye, J. C., Yan, W., Christos, P. J., Nori, D., & Ravi, A. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.03.012 · Cited by 65
Dickler, A., Kirk, M. C., Seif, N., Griem, K. L., Dowlatshahi, K., Francescatti, D., & Abrams, R. A. (2007) · Brachytherapy · doi:10.1016/j.brachy.2007.01.005 · Cited by 65
Haloua, M. H., Krekel, N. M. A., Jacobs, G. J. A., Zonderhuis, B. M., Bouman, M., Buncamper, M. E., Niessen, F. B., Winters, H. A. H., Terwee, C. B., Meijer, S., et al. (2014) · International Journal of Breast Cancer · doi:10.1155/2014/716860 · Cited by 65
Johns, N., & Dixon, J. M. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.08.016 · Cited by 66
Vaidya, J. S., Wenz, F. K., Bulsara, M. K., Tobias, J. S., Joseph, D. J., Saunders, C. M., Brew‐Graves, C., Potyka, I., Morris, S., Vaidya, H. J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20730 · Cited by 72
(2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.02.057 · Cited by 66
Radiation therapy-induced metastasis: radiobiology and clinical implications
Blyth, B. J., Cole, A., MacManus, M. P., & Martin, O. A. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9867-5 · Cited by 65
Baldwin, L., Taplin, S. H., Friedman, H., & Moe, R. E. (2004) · Cancer · doi:10.1002/cncr.20030 · Cited by 72
The Influence of Age on the Breast Surgery Decision-Making Process
Bleicher, R. J., Abrahamse, P. H., Hawley, S. T., Katz, S. J., & Morrow, M. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9708-x · Cited by 67
Preoperative localization of breast lesions: Current techniques
Mayo, R. C., Kalambo, M. J., & Parikh, J. R. (2019) · Clinical Imaging · doi:10.1016/j.clinimag.2019.01.013 · Cited by 64
A Dosimetric Comparison of IORT Techniques in Limited-Stage Breast Cancer
Nairz, O., Deutschmann, H., Kopp, M., Wurstbauer, K., Kametriser, G., Fastner, G., Merz, F., Reitsamer, R., Menzel, C., & Sedlmayer, F. (2006) · Strahlentherapie und Onkologie · doi:10.1007/s00066-006-1580-2 · Cited by 64
“The aim of breast IORT is an utmost precise dose delivery to the area at highest risk for contamination with subclinical tumor cells [1, 6, 7, 12, 27, 31].”
BackgroundSambasivaiah, K., Reddy, K. M., Yadagiri, L. A., Yutla, M., Venkata, P. B., Kadainti, S. V., & Reddy, R. P. (2007) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-5-56 · Cited by 65
Hattangadi-Gluth, J. A., Wo, J. Y.-L., Nguyen, P. L., Raad, R. F. A., Sreedhara, M., Niemierko, A., Freer, P. E., Georgian-Smith, D., Bellon, J. R., Wong, J. S., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.061 · Cited by 64
Nipple-Sparing Mastectomy in Patients with a History of Reduction Mammaplasty or Mastopexy
Alperovich, M. A., Tanna, N., Samra, F., Blechman, K. M., Shapiro, R. L., Guth, A. A., Axelrod, D., Choi, M., & Karp, N. S. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182865ad2 · Cited by 64
A Mixed-Reality System for Breast Surgical Planning
Perkins, S. L., Lin, M. A., Srinivasan, S., Wheeler, A. J., Hargreaves, B. A., & Daniel, B. L. (2017) · Proceedings - International Symposium on Mixed and Augmented Reality, ISMAR · doi:10.1109/ismar-adjunct.2017.92 · Cited by 64
Cloyd, J. M., Chen, H.-C., Wang, X., Tzeng, C.-W. D., Kim, M. P., Aloia, T. A., Vauthey, J., Lee, J. E., & Katz, M. H. G. (2019) · Pancreas · doi:10.1097/mpa.0000000000001231 · Cited by 64
Arcangeli, G., Pinnarò, P., Rambone, R., Giannarelli, D., & Benassi, M. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.040 · Cited by 64
Smith, R. P., Bloch, P., Harris, E. E. R., McDonough, J. E., Sarkar, A., Kassaee, A., Avery, S. G., & Solin, L. J. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.10.022 · Cited by 64
Lymph Node Dissection: Is It Diagnostic or Therapeutic?
Sigurdson, E. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.944 · Cited by 64
(2004) · The Women s Oncology Review · doi:10.1080/14733400500033664 · Cited by 63
Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids
Moura, B. S., Monteiro, M. V., Ferreira, L. P., Lavrador, P., Gaspar, V. M., & Mano, J. F. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202202825 · Cited by 60
Pyfer, B. J., Chatterjee, A., Chen, L., Nigriny, J. F., Czerniecki, B. J., Tchou, J. C., & Fisher, C. S. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4770-2 · Cited by 63
Rusthoven, K. E., Carter, D. L., Howell, K. T., Kercher, J. M., Henkenberns, P. L., Hunter, K. L., & Leonard, C. E. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.047 · Cited by 63
Kahn, J., Barrett, S., Forte, C., Stallard, S., Weiler-Mithoff, E. M., Doughty, J., & Romics, L. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.05.005 · Cited by 63
“5 [15-70] OUQ: 1 UIQ: 1 LOQ: 3 LIQ: 1 E [B-FF] 28.”
Bush, D. A., Slater, J. D., Garberoglio, C. A., Yuh, G. E., Hocko, J. M., & Slater, J. M. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318046354b · Cited by 63
Correlates of patient satisfaction and provider trust after breast‐conserving surgery
Waljee, J. F., Hu, E. S., Newman, L. A., & Alderman, A. K. (2008) · Cancer · doi:10.1002/cncr.23351 · Cited by 63
“Many patients have a choice between mastectomy and breast-conserving surgery (BCS), and the long-term survival after surgery is excellent.(1) Therefore, understanding the factors related to patient satisfaction with care is paramount to optimizing healthcare for these patients.”
BackgroundMammography and breast cancer: the new era
Tabár, L. K., & Dean, P. B. (2003) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(03)00262-5 · Cited by 63
Kunos, C. A., Latson, L., Overmoyer, B. A., Silverman, P., Shenk, R., Kinsella, T. J., & Lyons, J. A. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00181.x · Cited by 63
“(2) (NSABP B-06) S + WBRT (567) <<1 mm 20 (CI) 14% NR NR”
BackgroundAngiosarcoma of the breast: A difficult surgical challenge
Hui, A. C., Henderson, M. A., Speakman, D., & Skandarajah, A. R. (2012) · The Breast · doi:10.1016/j.breast.2012.01.001 · Cited by 63
Drukteinis, J. S., Gombos, E. C., Raza, S., Chikarmane, S. A., Swami, A., & Birdwell, R. L. (2012) · Radiographics · doi:10.1148/rg.321115016 · Cited by 63
de Bock, G. H., Putter, H., Bonnema, J., van der Hage, J. A., Bartelink, H. G. M. M., & van de Velde, C. J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0300-2 · Cited by 63
de Moraes, A. B., Zanini, R. R., Turchiello, M. S., Riboldi, J., & Medeiros, L. R. (2006) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2006001000028 · Cited by 63
Zhou, P., Gautam, S., & Recht, A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9268-y · Cited by 63
Morrow, N. V., Stepaniak, C., White, J. R., Wilson, J. F., & Li, X. A. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.056 · Cited by 63
Dooley, W. C., Vargas, H. I., Fenn, A. J., Tomaselli, M. B., & Harness, J. K. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0872-z · Cited by 65
“biopsy-proven invasive breast cancer, (3) patient was a candidate for mastectomy and was eligible for neoadjuvant”
BackgroundInfluentialSolin, L. J. (2010) · The Breast · doi:10.1016/j.breast.2009.11.004 · Cited by 63
Development of axillary surgery in breast cancer
Luini, A., Gatti, G., Ballardini, B., Zurrida, S., Galimberti, V. E., Veronesi, P., Vento, A. R., Monti, S., Viale, G., Paganelli, G., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi060 · Cited by 63
“The role and benefits of axillary dissection have been largely influenced by the National Surgical Adjuvant Breast Project (NSABP) B-04 trial and its subsequent follow-up data [8].”
BackgroundIntraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery
Smith, B. L., Hunt, K. K., Carr, D., Blumencranz, P. W., Hwang, E., Gadd, M. A., Stone, K., Dyess, D. L., Dodge, D. G., Valente, S. A., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200333 · Cited by 62
Breast Reconstruction: A Review and Rationale for Patient Selection
Nahabedian, M. Y. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31818b8c23 · Cited by 63
Kreike, B., Halfwerk, H., Kristel, P., Glas, A. M., Peterse, H. L., Bartelink, H. G. M. M., & van de Vijver, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0805 · Cited by 62
Johansson, B. H., Karlsson, L., Liljegren, G., Hardell, L., & Persliden, J. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.02.022 · Cited by 62
“Adjuvant WBRT after BCS has shown the same survival as mastectomy alone [10].”
BackgroundCoopey, S. B., Specht, M. C., Warren, L., Smith, B. L., Winograd, J. M., & Fleischmann, K. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2678-7 · Cited by 62
Evaluation of the antibacterial activity of patchouli oil.
Yang, X. Q., Zhang, X., Yang, S.-P., & Liu, W. (2013) · Europe PMC (PubMed Central) · Cited by 62
Bourland, J. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00006-x · Cited by 67
McGuire, A., Lowery, A., Kell, M., Kerin, M. J., & Sweeney, K. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6021-1 · Cited by 64
Gray, R. J., Forstner-Barthell, A. W., Pockaj, B. A., Schild, S. E., & Halyard, M. Y. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.12.062 · Cited by 62
“M reast-conserving therapy (BCT) and sentinel lymph node SLN) mapping and biopsy are the preferred treatment for ost women with early-stage breast cancer [1,2] As these reatment techniques have matured, implant augmentation f the breast has become one of the most commonly perormed cosmetic procedures.”
BackgroundEndoscopic Video-Assisted Breast Surgery: Procedures and Short-Term Results
Yamashita, K., & Shimizu, K. (2006) · Journal of Nippon Medical School · doi:10.1272/jnms.73.193 · Cited by 62
Polgár, C., Kahán, Z., Ivanov, O., Chorvath, M., Ligačová, A., Csejtei, A., Gábor, G., Landherr, L., Mangel, L., Mayer, A., et al. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610378 · Cited by 61
Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., Weber, S., Olson, C., Kenkare, P., Gomez, S. L., de Bruin, M. A., et al. (2013) · Cancer · doi:10.1002/cncr.28395 · Cited by 61
Lifestyle Factors and Survival in Women with Breast Cancer ,
Kushi, L. H., Kwan, M. L., Lee, M. M., & Ambrosone, C. B. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.236s · Cited by 65
“On the other hand, investigators interested in studies of breast cancer prognosis have generally ignored the potential role of dietary or other lifestyle factors and have instead focused on studies that examine modifications in adjuvant therapy, such as through cooperative oncology groups such as the National Surgical…”
Solin, L. J., Hwang, W., & Vapiwala, N. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.n.018 · Cited by 61
Clinical implementation of a new HDR brachytherapy device for partial breast irradiation
Scanderbeg, D. J., Yashar, C. M., Rice, R. K., & Pawlicki, T. A. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.09.024 · Cited by 61
“Data suggest that in properly selected patients there is no need for whole breast irradiation and accelerated partial breast irradiation (APBI) is acceptable [1–10].”
BackgroundKirby, A. M., Coles, C. E., & Yarnold, J. R. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.12.010 · Cited by 61
“The assumption rests largely on spatial patterns of LR after breast conservation surgery [39–51] (discussed in a recent review of the rationale for accelerated PBI [52]), and on the frequency and distribution of multifocal and multicentric foci reported in mastectomy specimens [53,54].”
BackgroundMethodHerskind, C., Griebel, J., Kraus-Tiefenbacher, U., & Wenz, F. K. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.009 · Cited by 61
“The main effect of WBRT in the EBCTCG meta-analysis and in the NSABP B-06 trial, in which lumpectomy was performed, was to reduce the initially steep increase in the cumulative recurrence incidence during the first 4 to 5 years after therapy (4, 25).”
BackgroundMethodInfluentialThe importance of surgical margins in breast cancer
Priddy, C. M. O., Forte, V. A., & Lang, J. E. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24047 · Cited by 61
“Twenty-year follow-up confirmed these findings [2].”
BackgroundAbe, S. E., Hill, J. S., Han, Y., Walsh, K. K., Symanowski, J. T., Hadžikadić-Gušić, L., Flippo-Morton, T. S., Sarantou, T., Forster, M. R., & White, R. L. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23990 · Cited by 61
“touching ink (NTTI) as the definition of a negative margin [16], while other randomized trials evaluating the outcomes of BCT used varying”
The Role of a Prone Setup in Breast Radiation Therapy
Huppert, N. E., Jozsef, G., DeWyngaert, K. J., & Formenti, S. C. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00031 · Cited by 61
“Nearly half a century later, breast conservation surgery with radiotherapy proved to achieve the same outcome as mastectomy, for both local control and survival (Fisher et al., 2002; Veronesi et al., 2002).”
BackgroundInfluentialRapid pathology of lumpectomy margins with open-top light-sheet (OTLS) microscopy
Chen, Y., Xie, W., Glaser, A. K., Reder, N. P., Mao, C., Dintzis, S. M., Vaughan, J. C., & Liu, J. T. C. (2019) · Biomedical Optics Express · doi:10.1364/boe.10.001257 · Cited by 62
Retrouvey, H., Kerrebijn, I., Metcalfe, K. A., O’Neill, A. C., McCready, D. R., Hofer, S. O. P., & Zhong, T. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07251-9 · Cited by 67
Dupont, E. L., Tsangaris, T. N., Garcia-Cantu, C., Howard-McNatt, M. M., Chiba, A., Berger, A. C., Levine, E. A., Gass, J. S., Gallagher, K. K., Lum, S. S., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003449 · Cited by 61
Stentz, N. C., Koelper, N., Barnhart, K. T., Sammel, M. D., & Senapati, S. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.09.007 · Cited by 64
Borghero, Y. O., Salehpour, M., McNeese, M. D., Stovall, M., Smith, S. A., Johnson, J. L., Perkins, G. H., Strom, E. A., Oh, J., Kirsner, S. M., et al. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.10.011 · Cited by 61
“Furthermore, in the 20-year follow-up report on 1800 patients from the National Surgical Adjuvant Breast and Bowel Project B-06 trial, patients who received breast irradiation did not experience an increased risk of developing contralateral breast cancer compared to patients randomly assigned to lumpectomy without adj…”
BackgroundGarcia, M. T., Mota, B. S., Cardoso, N., Martimbianco, A. L. C., Ricci, M. D., Carvalho, F. M., Gonçalves, R., Soares, J. M., & Filassi, J. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248768 · Cited by 61
Kirova, Y., Hijal, T., Campana, F., Fournier‐Bidoz, N., Stilhart, A., Dendale, R., & Fourquet, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.10.038 · Cited by 60
“Breast conserving surgery followed by whole breast radiotherapy (RT) is the standard of care in early-stage breast cancer [1,2].”
Al‐Hallaq, H., Mell, L. K., Bradley, J. A., Chen, L. F., Ali, A. N., Weichselbaum, R. R., Newstead, G. M., & Chmura, S. J. (2008) · Cancer · doi:10.1002/cncr.23872 · Cited by 62
Chansakul, T., Lai, K. C., & Slanetz, P. J. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.6881 · Cited by 61
“Given equivalent survival rates for breast conservation therapy and mastectomy [2–8], breast conservation therapy has become the treatment of choice for early-stage breast cancer.”
BackgroundNeuroendocrine breast tumours: Breast cancer or neuroendocrine cancer presenting in the breast?
Adams, R., Dyson, P., & Barthelmes, L. (2013) · The Breast · doi:10.1016/j.breast.2013.11.005 · Cited by 60
“Unlike usual-type breast cancers, however, where breast-conserving surgery is evidence based [73,74], the evidence for the use of breast conserving surgery for NETs of the breast is anecdotal.”
BackgroundPediconi, F., Miglio, E., Telesca, M., Luciani, M. L., Kirchin, M. A., Passariello, R., & Catalano, C. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e318230061c · Cited by 60
Tumor bed delineation for external beam accelerated partial breast irradiation: A systematic review
Yang, J. T., Tao, R., Elkhuizen, P. H. M., van Vliet-Vroegindeweij, C., Li, G., & Powell, S. N. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.028 · Cited by 62
“Three of the largest trials with twenty-year follow-up demonstrated equivalent survival between patients who received BCT compared to mastectomy [3–5].”
BackgroundResultThe Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer
Coopey, S. B., Smith, B. L., Hanson, S., Buckley, J. M., Hughes, K. S., Gadd, M. A., & Specht, M. C. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1802-4 · Cited by 60
Fisher, S., Gao, H., Yasui, Y., Dabbs, K., & Winget, M. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv107 · Cited by 60
Breast MRI in the Evaluation of Eligibility for Accelerated Partial Breast Irradiation
Godinez, J., Gombos, E. C., Chikarmane, S. A., Griffin, G. K., & Birdwell, R. L. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3465 · Cited by 60
“© American Roentgen Ray Society B reast-conserving therapy, which consists of lumpectomy and wholebreast irradiation, is considered the standard of care for early-stage breast cancer (stages I and II) and results in survival equivalent to that observed after mastectomy [1–8].”
BackgroundAalders, K. C., van Bommel, A. C. M., van Dalen, T., Sonke, G. S., van Diest, P. J., Boersma, L. J., & van der Loo, M. V. D. H. –. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.05.010 · Cited by 71
Ahmed, K. A., Liveringhouse, C. L., Mills, M. N., Figura, N. B., Grass, G. D., Washington, I. R., Harris, E. E. R., Czerniecki, B. J., Blumencranz, P. W., Eschrich, S. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.019 · Cited by 62
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges
Kaidar‐Person, O., Offersen, B. V., Boersma, L. J., Ruysscher, D. D., Tramm, T., Kühn, T., Gentilini, O., Mátrai, Z., & Poortmans, P. M. (2021) · The Breast · doi:10.1016/j.breast.2021.02.004 · Cited by 60
Bhatnagar, A. K., Brandner, E. D., Sonnik, D., Wu, A. E., Kalnicki, S., Deutsch, M., & Heron, D. E. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9032-8 · Cited by 60
Self-citationKijima, Y., Yoshinaka, H., Owaki, T., & Aikou, T. (2006) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2006.06.004 · Cited by 60
Suga, T., Ishikawa, A., Kohda, M., Otsuka, Y., Yamada, S., Yamamoto, N., Shibamoto, Y., Ogawa, Y., Nomura, K., Sho, K., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.021 · Cited by 60
External-beam partial-breast irradiation
Formenti, S. C. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.10.008 · Cited by 60
Pierce, L. J., Moughan, J., White, J. R., Winchester, D. P., Owen, J. B., & Wilson, J. F. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.019 · Cited by 61
Caldon, L. J. M., Collins, K., Reed, M., Sivell, S., Austoker, J., Clements, A., Patnick, J., Elwyn, G. J., & BresDex Group (2010) · Health Expectations · doi:10.1111/j.1369-7625.2010.00633.x · Cited by 69
Merrill, A. L., Coopey, S. B., Tang, R., McEvoy, M. P., Specht, M., Hughes, K. S., Gadd, M. A., & Smith, B. L. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4916-2 · Cited by 59
Killelea, B. K., Long, J. B., Chagpar, A. B., Ma, X., Soulos, P. R., Ross, J. S., & Gross, C. P. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2656-1 · Cited by 59
Impact of Volumetric Modulated Arc Therapy Technique on Treatment With Partial Breast Irradiation
Qiu, J., Chang, Z., Wu, Q., Yoo, S., Horton, J. K., & Yin, F.-F. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.036 · Cited by 59
Kinoshita, R., Shimizu, S., Taguchi, H., Katoh, N., Fujino, M., Onimaru, R., Aoyama, H., Katoh, F., Omatsu, T., Ishikawa, M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.003 · Cited by 60
Fields, E. C., DeWitt, P. E., Fisher, C. M., & Rabinovitch, R. A. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.07.016 · Cited by 59
Progress and controversies: Radiation therapy for invasive breast cancer
Jagsi, R. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21209 · Cited by 64
“2% after lumpectomy alone.(3) Only more recently has the impact of radiotherapy on overall survival in this setting been demonstrated.”
BackgroundPleijhuis, R. G., Kwast, A. B. G., Jansen, L., de Vries, J., Lanting, R., Bart, J., Wiggers, T., van Dam, G. M., & Siesling, S. (2013) · The Breast · doi:10.1016/j.breast.2013.01.010 · Cited by 59
Yıldırım, E., & Berberoğlu, U. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0487-5 · Cited by 59
Marincola, B. C., Pediconi, F., Anzidei, M., Miglio, E., Mare, L. D., Telesca, M., Mancini, M., d’Amati, G., Monti, M., Catalano, C., et al. (2014) · Expert Review of Medical Devices · doi:10.1586/17434440.2015.986096 · Cited by 59
“Several trials have reported that breast surgery, either conservative or radical, can be considered a safe and effective first-line treatment for early breast cancer, with a long-term survival rate substantially superimposable between women who undergo breast-conserving surgery and radical mastectomy [1,2].”
BackgroundRisk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years
Vieira, R. A. D. C., da Costa, A. M., de Souza, J. L., Coelho, R. R., de Oliveira, C. Z., Sarri, A. J., Affonso, R. J., & Zucca‐Matthes, G. (2015) · Breast Care · doi:10.1159/000442489 · Cited by 59
Gass, J. S., Onstad, M. A., Pesek, S. E., Rojas, K. E., Fogarty, S., Stuckey, A. R., Raker, C., & Dizon, D. S. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5905-4 · Cited by 59
Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer
Koppiker, C. B., Noor, A. U., Dixit, S., Busheri, L., Sharan, G. K., Dhar, U., Allampati, H. K., & Nare, S. (2019) · International Journal of Breast Cancer · doi:10.1155/2019/4262589 · Cited by 60
Metadata
- Authors
- Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N.
- Affiliations
- University of Pittsburgh (US)
- NSABP Foundation (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-17
- Volume
- 347
- Issue
- 16
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2067420088
- Semantic Scholar
- 4468d9b99c6cf981372c46aebe6895549bc34b70
- Cited by
- 6,249
- References
- 28
- Citations by year
- 2026: 190 · 2025: 212 · 2024: 241 · 2023: 306 · 2022: 302 · 2021: 328 · 2020: 320 · 2019: 290 · 2018: 284 · 2017: 289 · 2016: 334 · 2015: 340 · 2014: 318 · 2013: 331 · 2012: 321
- FWCI
- 52.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U10-CA37377, U10CA069651, U10CA037377, U10CA069974, U10 CA 69651, U10-CA-69974)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- invasive breast cancer, total mastectomy, breast-conserving surgery, breast cancer radiotherapy, breast-conserving therapy, ipsilateral breast tumor recurrence, disease-free survival, overall survival, long-term outcomes
- MeSH terms
- Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Mastectomy, Radical, Mastectomy, Segmental, Incidence, Survival Analysis, Randomized Controlled Trials as Topic, Neoplasms, Second Primary, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.